Medicus Pharma Ltd.

CA MDCX

2.55CAD
-0.15(5.56%)

Last update at 2024-11-21T15:34:00Z

Day Range

2.553.00

LowHigh

52 Week Range

2.207.60

LowHigh

Fundamentals

Previous Close 2.70
Market Cap72.13M
Volume1029
P/E Ratio-
Dividend Yield-%
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-3.52

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Income before tax	-6.78414M	-1.69238M	-2.05526M
Minority interest	-	-	-
Net income	-6.78414M	-1.69238M	-2.05526M
Selling general administrative	2.82M	0.33M	0.26M
Selling and marketing expenses	-	-	-
Gross profit	-	-	-
Reconciled depreciation	-	-	-
Ebit	-	-	-
Ebitda	-	-	-
Depreciation and amortization	-	-	-
Non operating income net other	-	-	-
Operating income	-3.01210M	-0.97842M	-1.44139M
Other operating expenses	-	-	-
Interest expense	0.74M	0.53M	0.12M
Tax provision	-	-	-
Interest income	-	-	-
Net interest income	-1.17068M	-1.10227M	-0.69085M
Extraordinary items	-	-	-
Non recurring	-	-	-
Other items	-	-	-
Income tax expense	-	-	-
Total revenue	0.00000M	0.00000M	0.00000M
Total operating expenses	3.01M	0.98M	1.44M
Cost of revenue	-	-	-
Total other income expense net	-2.60136M	0.39M	0.08M
Discontinued operations	-	-	-
Net income from continuing ops	-6.78414M	-1.69238M	-2.05526M
Net income applicable to common shares	-	-	-
Preferred stock and other adjustments	-	-	-

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Total assets	1.89M	0.28M	0.08M
Intangible assets	-	-	-
Earning assets	-	-	-
Other current assets	-	-	-
Total liab	1.09M	12.48M	10.58M
Total stockholder equity	0.81M	-12.19803M	-10.50565M
Deferred long term liab	-	-	-
Other current liab	-	10.85M	9.75M
Common stock	-	-	-
Capital stock	19.84M	0.19M	0.19M
Retained earnings	-19.17671M	-12.39257M	-10.70019M
Other liab	-	-	-
Good will	-	-	-
Other assets	-	-	-
Cash	1.72M	0.27M	0.08M
Cash and equivalents	-	-	-
Total current liabilities	1.09M	12.48M	10.58M
Current deferred revenue	-	-	-
Net debt	-	1.26M	0.59M
Short term debt	-	-	-
Short long term debt	-	1.53M	0.67M
Short long term debt total	-	-	-
Other stockholder equity	-	-	-
Property plant equipment	-	-	-
Total current assets	1.89M	0.28M	0.08M
Long term investments	-	-	-
Net tangible assets	-	-	-
Short term investments	-	-	-
Net receivables	-	-	-
Long term debt	-	-	-
Inventory	-	-	-
Accounts payable	-	-	-
Total permanent equity	-	-	-
Noncontrolling interest in consolidated entity	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-
Accumulated other comprehensive income	-	-	-
Additional paid in capital	-	-	-
Common stock total equity	-	-	-
Preferred stock total equity	-	-	-
Retained earnings total equity	-	-	-
Treasury stock	-	-	-
Accumulated amortization	-	-	-
Non currrent assets other	-	-	-
Deferred long term asset charges	-	-	-
Non current assets total	0.00000M	0.00000M	0.00000M
Capital lease obligations	-	-	-
Long term debt total	-	-	-

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Investments	-	-	-
Change to liabilities	-	-	-
Total cashflows from investing activities	-	-	-
Net borrowings	-	-	-
Total cash from financing activities	5.61M	1.25M	0.88M
Change to operating activities	-	-	-
Net income	-6.78414M	-1.69238M	-2.05526M
Change in cash	1.45M	0.19M	-0.56566M
Begin period cash flow	0.27M	0.08M	0.64M
End period cash flow	1.72M	0.27M	0.08M
Total cash from operating activities	-4.15826M	-1.05710M	-1.44805M
Issuance of capital stock	-	-	-
Depreciation	-	-	-
Other cashflows from investing activities	-	-	-
Dividends paid	-	-	-
Change to inventory	-	-	-
Change to account receivables	-	-	-
Sale purchase of stock	-	-	-
Other cashflows from financing activities	-	-	-
Change to netincome	-	-	-
Capital expenditures	0.00000M	0.00000M	0.00000M
Change receivables	-	-	-
Cash flows other operating	-	-	-
Exchange rate changes	-	-	-
Cash and cash equivalents changes	-	-	-
Change in working capital	0.83M	-0.07869M	-0.00666M
Stock based compensation	0.15M	0.00000M	-
Other non cash items	1.65M	0.71M	0.61M
Free cash flow	-4.15826M	-1.05710M	-1.44805M

Peer Comparison

Sector: Industry:

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)
MDCX Medicus Pharma Ltd.	-0.15 5.56%	2.55	-	-	-	8.06
SAGE Sage Potash Corp.	-0.02 10.00%	0.18	-	-	-	11.50
NOB Noble Mineral Exploration Inc	0.005 14.29%	0.04	1.05	-	-	2.02	-5.1558
IBAT International Battery Metals Ltd.	-0.05 14.29%	0.30	-	-	-	-

Reports Covered

View All

Key Executives

Name	Title	Year Born
Carolyn Bonner	Pres	NA
Mr. James P. Quinlan	Chief Financial Officer	NA
Dr. Huma Qamar CMI, M.D., M.P.H.	Chief Scientific Officer and Head of R&D Program	NA
Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D.	Chief Medical Officer	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.